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stroma, which is activated in the proximity of a tumor. Activated stroma is often characterized by the molecular expression of
a-smooth muscle actin (a-SMA) within fibroblasts. However, the precise spatial and temporal evolution of chemical changes
in fibroblasts upon epithelial tumor signaling is poorly understood. Here we report a label-free method to characterize fibroblast
changes by using Fourier transform infrared spectroscopic imaging and comparing spectra with a-SMA expression in primary
normal human fibroblasts. We recorded the fibroblast activation process by spectroscopic imaging using increasingly tissue-like
conditions: 1), stimulation with the growth factor TGFb1; 2), coculture with MCF-7 human breast cancerous epithelial cells in
Transwell coculture; and 3), coculture with MCF-7 in three-dimensional cell culture. Finally, we compared the spectral signatures
of stromal transformation with normal and malignant human breast tissue biopsies. The results indicate that this approach
reveals temporally complex spectral changes and thus provides a richer assessment than simple molecular imaging based
on a-SMA expression. Some changes are conserved across culture conditions and in human tissue, providing a label-free
method to monitor stromal transformations.INTRODUCTIONThe stroma is known to play a crucial role in epithelial
cancer progression in a variety of tissues (1–4). The stroma
has also been suggested as an alternative and potentially
more effective therapeutic target to the epithelial tumor
itself because the vast heterogeneity in the genomic and
histological makeup of epithelial tumors makes individual-
ized treatment expensive and unreliable (5). It is imperative
to develop methods to characterize the stroma and hence
its transformations in epithelial tumor progression. For
example, one hallmark of a cancer-associated stroma is
the fibroblast-to-myofibroblast cellular transformation (6).
This phenotypic change is characterized by the expression
of a-smooth muscle actin (a-SMA), a cytoplasmic protein
that increases a cell’s contractility and leads to stiffening
of the tumor microenvironment (7). The fibroblast-to-myo-
fibroblast transformation has been observed within tumor-
adjacent stroma in human tissues (8–10). A similar response
can be induced by exposing fibroblasts to elevated levels of
transforming growth factor-b1 (TGF-b1) in cell culture
(11). Because of this readily observable transition and its
effect on the physical properties of the tissue, stromal myo-
fibroblasts have been a focus of research and are important
markers in glandular cancers such as breast cancer (10,11).
Immunohistochemistry (IHC) is the gold standard for
visualizing a-SMA expression in clinical samples, but the
use of antibody-based techniques is time-consuming and
costly, and it is difficult to quantify protein expression (12).
Furthermore, the stromal response is likely more complexSubmitted March 26, 2011, and accepted for publication July 14, 2011.
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able advances in immunofluorescence methods have been
made (13), only a few known proteins can be simultaneously
detected. Even this capability may not be sufficient to
catalog the varied cytopathic effects of a multifactorial
disease like cancer. Alternative techniques to directly mea-
sure cellular transformations in a consistent, quantitative,
and multiplexed manner are needed.
As an alternative to molecular imaging, label-free chem-
ical imaging approaches have recently provided reliable
correlations between histopathologic status and spectral
markers (14–16). Fourier transform infrared (FTIR) spectro-
scopic imaging, in particular, has been used extensively to
study biochemical changes within cells as well as differ-
ences between cell lines (17–19). In addition, studies have
correlated molecular expression in simple breast cell
cultures with spectral properties in both IR (20) and Raman
spectroscopy (21). These studies focused on epithelial cells.
The fibroblasts’ response to epithelial transformations has
not been studied in vitro by spectroscopic imaging tech-
niques. Here, we describe a method for characterizing and
analyzing the fibroblast-to-myofibroblast transformation.
We specifically seek to examine the correlation between
the current gold-standard antibody marker and the spectro-
scopic signature of transformation. We examine transforma-
tion in primary normal human dermal fibroblasts (NHDFs)
activated with TGFb1, in cocultures of primary fibroblasts
with tumorigenic breast epithelial cells (MCF-7) and human
tissues. Although coculture models provide a tissue-like
environment, TGFb1 activation is used as a positive control
because it is commonly used in research (7). This compre-
hensive examination of cells grown in two-dimensionaldoi: 10.1016/j.bpj.2011.07.055
1514 Holton et al.(2D) and three-dimensional (3D) cell cultures as well as in
human breast tissue will ensure wide research and clinical
relevance. However, the presence of other cell types is
a potentially confounding analytical factor, and it is not
obvious that spectral correlations will hold for mixtures of
cell types. Hence, this study is important from the perspec-
tive of clinical cancer progression, research in correlating
labeled and label-free approaches, and analysis of samples
that present a complex bioanalytical background.MATERIALS AND METHODS
Experimental design
Cell culture models
To observe the effects of cancerous breast epithelium on the surrounding
tissue stroma, we used two coculture methods: a Transwell coculture and
a 3D cellular coculture model. The Transwell coculture (Fig. 1 A) allows
for two cell types to communicate via soluble growth factors that diffuse
into a shared medium (22). The 3D cellular coculture model (Fig. 1 B)
consists of cells embedded in a type I collagen hydrogel. Both of these
systems are essentially mediated by soluble growth factors; however, cells
adhere to a solid substrate in the 2D model and have a different geometry
and physical microenvironment. Although 2D monolayer cultures are the
staple of cell biology, 3D cultures were recently shown to be a more real-
istic representation of biological phenomena that occur in tissue (23–28).
Hence, an analysis of both systems by means of our approach serves to
ensure that the developed method is robust and relevant to different commu-
nities of researchers. In addition to these cocultures, we sought to demon-
strate that the developed methods are also valid for 2D and 3D cultures of
single-cell types. Therefore, we stimulated single-cell-type cultures with
TGFb1 to validate the observed activation.
For 2D cultures, primary NHDFs were grown on MirrIR slides, which
allowed for both FTIR transflectance and immunofluorescence imaging.
The fibroblasts were cocultured with cancerous breast epithelial cells
(MCF-7) or stimulated with TGFb1. The MCF-7 cells were derived from
a human breast tumor that had metastasized to the lung but maintain aFIGURE 1 (A) Schematic of the Transwell coculture system, which
allows cells to communicate via soluble growth factors without contact.
A filter with a 0.1 mm pore size is used at the bottom of the top basket.
(B) Schematic of the 3D coculture setup, which is comprised of cells
embedded in a type I collagen gel. No membrane separates the layers.
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sive when injected into nude mice compared with other human breast
cancer cell lines, and hence were used in this study as a model of an early
cancerous source. Samples were removed from the culture at specific time
points (0 h, 6 h, 12 h, and 24 h) and fixed. We analyzed half of the samples
using immunofluorescence to detect a-SMA, and spectroscopically imaged
the other half. For 3D cultures, samples were prepared as separate layers,
with one cell type (NHDF and MCF-7) per layer in a type I collagen matrix.
The layers were cocultured for a determined length of time and then sepa-
rated with forceps. There was no observed cell migration within the time
intervals of this experiment, as determined by cell-type-specific expression
of cytokeratins for epithelial cells and vimentin for fibroblasts (data not
shown). Briefly, the layers were separated, stained according to standard
IHC methods, and subsequently imaged with a Zeiss Axiovert 200M (Zeiss,
Thornwood, NY). A similar 3D model was previously used to study skin
cancer (29). Although the experimental methods employed for both this
study and the engineered skin model can be used to study epithelial-fibro-
blast interactions, the predefined geometry used here allows one to observe
molecular changes without morphology-associated effects or changes in
the molecular concentration of a growing tumor, which may confound
the temporal profile.
Cell culture
Cell lines and use. Primary adult NHDFs (No. CC-2511; Lonza, Basel,
Switzerland) were maintained in fibroblast basal medium supplemented
with 0.1% hFGF-B, 0.1% insulin, 0.1% gentamicin/amphotericin-B, and
2% fetal bovine serum (FBS; FGM-2 fibroblast growth medium-2 bullet
kit, No. CC3132; Lonza). They were used at passages 8–10 to avoid prob-
lems associated with senescence in primary cell lines. The fibroblasts were
subcultured according to protocols detailed on the Lonza website, and the
Lonza ReagentPack (trypsin/EDTA, trypsin neutralizing solution, HEPES
buffered saline solution, No. CC-5034) was used exclusively with this
cell type. For serum-free medium, the media were prepared the same
way, with the exception that FBS was omitted. MCF-7 (ATCC) cells
were maintained in Dulbecco’s modified Eagle’s essential medium (Invitro-
gen, Carlsbad, CA) supplemented with 10% FBS (Sigma, St. Louis, MO)
and 1% PenStrep (Sigma). They were subcultured according to ATCC
protocols every 3 days at 70% confluency.
2D cell culture. Fibroblasts were grown on sterilized MirrIR slides
(Kevley Technologies, Chesterland, OH). They were seeded at ~60% con-
fluency and grown for 24 h before being switched to serum-free medium
(FGM-2 (Lonza), with additives but not FBS). The samples were grown
in serum-free medium for 24 h before coculture. MCF-7 cells were grown
on Transwell inserts (0.1 mm pore size; Corning, Corning, NY) in normal
growth medium for 24 h and then switched to serum-free medium for an
additional 24 h before coculture.
Transwell coculture. The Transwell coculture system is useful for spec-
troscopy because any IR substrate can be used in the lower chamber of
the culture dish (Transwell inserts, 0.1 mm pore, PES; Corning). Pieces of
MirrIR Low-E slides were sterilized once with 10% bleach followed by
70% ethanol and left to dry in a sterile biosafety cabinet before use. Immu-
nofluorescence staining was also performed with the MirrIR slides, and
there were no detrimental effects on the coated glass surface. The use of
MirrIR slides for both immunofluorescence and FTIR measurements
ensured that there was no substrate-specific factor that could have induced
a-SMA expression independently of soluble growth factors. After 0 h, 6 h,
12 h, and 24 h of coculture, each MirrIR slide was rinsed with sterile
1 PBS before fixation in 4% paraformaldehyde for 1 h at 4C. After
fixation, the paraformaldehyde was neutralized with 0.1 M glycine for
10 min. Subsequently, the samples were divided: for each time point, two
samples were prepared for FTIR imaging and two were prepared for immu-
nofluorescence staining. The samples for FTIR imaging were rinsed with
deionized water and left to dry before imaging.
3D cell culture. The cells were maintained as previously described in 2D
culture before being suspended in collagen hydrogels (Type I derived from
Label-Free Imaging of Fibroblasts 1515rat tail; BD Biosciences, Franklin Lakes, NJ). All reagents were kept on ice
before plating, because collagen solution will gel slightly at room temper-
ature. In a conical tube on ice, collagen stock solution was diluted to
2 mg/mL with sterile 10 PBS. The cells were trypsinized, centrifuged
at 1000 rpm for 3 min, and resuspended in growth medium. After the cells
were counted, they were suspended in the collagen solution at a cell density
of 420 cells/mL for NHDF and 1.9  104 cells/mL for MCF-7. A much
lower cell density of fibroblasts than epithelial cells was used because of
the tendency of fibroblasts to collapse the hydrogel at high cell density
and after activation, and the similarity to fibroblast density in real tissue.
Finally, 1 N NaOH was added at 0.023 mL per 1 mL of collagen stock solu-
tion to neutralize the acetic acid and allow the collagen to gel. To prepare
samples, 200 mL of the collagen and cell suspension were added to each
well of a 48-well tissue culture plate. The plates were left at 4C for
90 min to slow down the polymerization of collagen and obtain a more
uniform fiber orientation and width (31). The samples were then placed
in a humidified incubator at 37C for 30 min to polymerize the collagen
with cells embedded within. After the samples had gelled, growth medium
was added. The cells were allowed to grow for 24 h before being changed to
serum-free medium to avoid any confounding effects of growth factors
present in FBS. After 48 h in serum-free medium, the coculture layers
were stacked together, and 1.5 ng/mL transforming growth factor-b1
(TGFb1) from human platelets (R97%, No. T1654; Sigma) in serum-
free medium were added to the appropriate fibroblast samples as a positive
control. Fresh serum-free medium was added to the cocultured samples.
After 0, 6, 12, and 24 h of coculture, the fibroblast layer was fixed in 4%
paraformaldehyde overnight before processing for immunofluorescence
or FTIR imaging.
3D culture sample preparation. 3D culture samples were paraffin-
embedded and sectioned before imaging. First, the paraformaldehyde was
gently aspirated from the samples and then the gels were dehydrated by
serial ethanol dehydration. The samples were put in 50%, 70%, 80%, and
95% ethanol for 45 min each, followed by three 45-min incubations in
100% ethanol. The samples were then soaked in xylenes for three 45-min
periods. Finally, the samples were placed in paraffin in a 60C oven for
two 1-h periods and one 12-h period. The samples were mounted in paraffin
blocks and sectioned at 5 mm onto MirrIR slides for FTIR imaging. The
samples were deparaffinized in hexanes for 24 h before imaging. For
each set of experiments, samples were prepared in duplicate and the exper-
iment was replicated independently to show the reproducibility of both the
biological results and absorbance spectra.
Immunofluorescence staining. For immunofluorescence staining, samples
were permeabilized in 0.2% TX-100 for 15 min. The samples were washed
three times with PBS and then blocked with 1 wt% BSA in PBS/T for 1.5 h.
After three washes with PBS/T, the samples were incubated with primary
antibody (mouse anti-human a-SMA, 1:100 dilution; Dako, Glostrup,
Denmark) overnight at 4C. The samples were washed again and incubated
with secondary antibody (goat anti-mouse IgG-FITC conjugated, 1:80 dilu-
tion; Abcam, Cambridge, UK) for 1 h. The samples were mounted with
UltraCruz mounting medium for fluorescence with DAPI (No. sc-24941;
Santa Cruz Biotechnology, Santa Cruz, CA) and imaged with a Zeiss
Axiovert 200M fluorescence microscope. For 3D samples, confocal imag-
ing was performed with a Leica SP2 laser scanning confocal microscope
(Leica, Wetzlar, Germany).
Immunohistochemistry. For tissue biopsies, we obtained a tissue microar-
ray (TMA) of 96 1.5-mm human breast tissue cores comprised of normal,
epithelial hyperplasia, in situ, benign tumors, and malignant cancer tissues
(No. BR961; US Biomax, Rockville, MD). Four serial sections were
acquired from the TMA block. One 5-mm-thick tissue section was placed
on a BaF2 substrate for FTIR analyses, and three 5-mm-thick tissue sections
were placed on standard glass slides for IHC and hematoxylin and eosin
(H&E) staining. IHC staining was performed for vimentin and a-SMA.
H&E staining was used for tissue visualization. Staining was performed
with the use of a Ventana Benchmark XT automated slide preparation
system (Ventana Medical Systems, Tucson, AZ) and Ventana clinical proto-
cols and reagents (XT UltraView DAB protocol;Ventana).FTIR spectroscopic imaging. FTIR spectroscopic imaging data were re-
corded with the use of a Perkin Elmer Spotlight 400 imaging system (Perkin
Elmer, Waltham, MA). For all cellular samples, both confluent and sparse
regions of the sample were imaged in transflection mode, and data from
4000 cm1 to 750 cm1 were saved. A spectral resolution of 8 cm1 was
set with 32 scans per pixel averaged to provide higher signal/noise
ratio data. An interferometer speed of 1.0 cm/s was used, and a pixel size
of 6.25  6.25 mm was used for detection with an MCT linear array. A
spectral background was collected on the MirrIR slide using the same
parameters but with 120 scans per pixel. Atmospheric correction was
performed on the Spotlight instrument, and the files were exported into
ENVI-IDL. Images were baseline-corrected and only those pixels with an
absorbance > 0.015 a.u. for the peak absorbance at 1656 cm1 (Amide I)
were used for further analysis. Spectra were normalized to Amide I to
account for variances in cell density.
Absorbance was stronger for the TMA data, and we sought to maintain
compatibility with earlier studies on the parameters used. We collected
sample data using the same scanning parameters employed for the cell
culture samples, with the exceptions of a 4 cm1 resolution with 2 scans
per pixel and a mirror speed of 2.2 cm/s. A background was acquired at
these parameters with 120 scans averaged. A threshold absorbance of
0.03 a.u. for the 1656 cm1 (Amide I) absorbance peak was employed to
determine pixels to be included in the analysis. Regions of interest were
manually marked on the absorbance images corresponding to regions of
either fibroblast or myofibroblast cells. Cell-type assignations were made
based on the IHC staining of the serial tissue sections: fibroblasts stained
positive for vimentin and negative for a-SMA, and myofibroblasts stained
positive for both vimentin and a-SMA. More than 40,000 pixels corre-
sponding to fibroblasts and >150,000 pixels corresponding to myofibro-
blasts were identified. From these identified pixels, average spectra were
obtained for fibroblast and myofibroblast classes.RESULTS AND DISCUSSION
The well-characterized fibroblast activation pathway serves
as a model system to benchmark spectral (chemical)
changes that accompany the phenotypic transformation.
We first used the Transwell coculture system to determine
whether coculturing normal primary fibroblasts with tumor-
igenic breast epithelial cells could result in an activated
phenotype, as shown previously in fibroblasts isolated
from stroma surrounding a tumor in vivo (7) as well as after
induction by TGFb1 in vitro (9). In our coculture with
MCF-7 cells, phenotypic changes were induced in the pri-
mary dermal fibroblasts within 6 h to the same extent as
treatment with 1.5 ng/mL TGFb1 (Fig. 2). The experiment
was repeated for both cases over a time course of 24 h,
with time points being taken at 0 (no coculture), 6, 12,
and 24 h to observe any potential evolution of this marker
over time. The immunofluorescence imaging results showed
no visible change in the number of cells expressing a-SMA
over time. We did not use any digitally assisted methods to
compare intensity levels, because nonspecific fluorescence
and photobleaching make it difficult to perform quantitative
intensity analyses. Both stimulation with TGFb1 and cocul-
ture with MCF-7 activated fibroblasts within 6 h.
We hypothesized that examining the temporal evolution
of IR absorption spectra would yield more information
about fibroblast activation than the on-off information
derived from immunofluorescence expression of a singleBiophysical Journal 101(6) 1513–1521
FIGURE 3 Top: In fibroblasts cocultured with MCF-7 (A) or stimulated
with 1.5 ng/mL TGFb1 (B), normal dermal fibroblasts exhibit changes
primarily in the asymmetric and symmetric phosphate stretching bands,
indicating bulk changes in the quantity of nucleic acids over time, normal-
ized to 1656 cm1 (Amide I). Fibroblasts activated through coculture show
sustained levels of nucleic acids over time, whereas levels wane in the
TGFb1-activated fibroblasts. Bottom: Comparison of the C-H stretching
region for fibroblasts cocultured with MCF-7 cells (A) or stimulated with
TGFb1 (B). Peaks in the C-H stretching region of the spectrum
(2960 cm1, 2932 cm1, and 2850 cm1) have a much higher absorbance
in the 12- and 24-h time points compared with control. This suggests an
increase in cell metabolism resulting from higher amounts of fatty acids.
After 6 h of TGFb1 stimulation, the fibroblasts show lower absorbance in
this region compared with control and MCF-7 coculture.
FIGURE 2 After 6 h of stimulation with 1.5 ng/mLTGFb1 (A) or 6 h of
coculture with MCF-7 cells (B), a-SMA is expressed in dermal fibroblasts.
(C) Confocal microscopy was used to visualize a-SMA expression in fibro-
blasts for 3D systems. Scale bar represents 50 mm.
1516 Holton et al.biomarker. Spectra measured from fibroblasts are shown in
Fig. 3. Changes were primarily seen in the biomolecular
fingerprint region (1800–950 cm1) and the C-H stretching
region (3000–2875 cm1). In the fingerprint region, larger
changes were seen in peaks at 1080 cm1 and 1224 cm1
(Fig. 3, top). These are the asymmetric and symmetric
vibrational modes of the phosphate bond, which is indica-
tive of changes in nucleic acids. There is an increase in
the 1080 cm1 peak, which is usually associated with the
symmetric phosphate stretching of DNA. These spectra
are averaged to cell density, and the cells were serum-
starved before the experiment began, so there should have
been little cellular proliferation over the 24 h time course.
Serum-starving the cells before coculture arrests them at
G0/G1, and this should minimize spectral differences in
1080 cm1 that can be attributed to cells being in different
phases of the cell cycle (32–34). The increase at 1080 cm1
indicates that unless there is an increased amount of DNA
present in the cells, the assignment of this peak to the phos-
phate bond of DNA alone may be uncertain. If we account
for the total amount of genetic material present within the
cell (RNA, DNA, and associated proteins), we may obtain
some explanation for the increase in absorbance at this
peak. The spectral changes seen could be due to an increase
in RNA, changes in chromatin 3D configuration, chromatin
sequestration, or an increase in the size of the nucleus.
In a recent study, Whelan et al. (35) attributed changes in
the 1080 cm1 peak to a transition between native B- and
A-like forms of DNA upon dehydration of intact cells. We
do not anticipate that the changes seen in these experiments
were due to this transition, because all of the samples were
fixed and dried completely before spectroscopic imaging
was performed.
Between the two treatments (MCF-7 coculture and
TGFb1 stimulation), we observed similar molecular expres-Biophysical Journal 101(6) 1513–1521sion of a-SMA but differences in absorption at 1080 cm1.
In the TGFb1-stimulated samples, the 6- and 12-h samples
had an increase in absorption at 1080 cm1 compared with
the control, but after 24 h the level had fallen back to the
control value. Of interest, at 1224 cm1, the 6- and 24-h
time points were elevated but the 12-h sample had lower
absorption than the control. This discrepancy could be the
result of the cells being stimulated with TGFb1 only once
at the beginning of the experiment. Thus, the 6-h sample
would have a sustained level of TGFb1 in the medium
before the cells were fixed, whereas in the 24-h sample
the concentration of TGFb1 present in the medium would
have decreased because it had already been metabolized
by the cells. However, in the samples that were cocultured
FIGURE 4 (A) Characteristic absorbance peaks associated with collagen
(1283 cm1, 1236 cm1, and 1204 cm1) are visible and elevated in fibro-
blasts after coculture with MCF-7. At 1080 cm1 in both 3D and 2D
cultures (Fig. 3 B), the same cyclical phenomenon is seen. (B) The C-H
stretching region of the spectrum is distinct from that of the Transwell
coculture (Fig. 3 B, bottom) spectra.
Label-Free Imaging of Fibroblasts 1517with MCF-7 cells, there was a uniform level of growth
factors secreted by the epithelial cells into the shared
medium throughout the time course of the experiment.
Therefore, we believe that the absorbance at 1224 cm1
may be used as a marker for a sustained fibroblast response
to molecular signals released by a malignant epithelium.
In the C-H stretching region, changes were seen in peaks
at 2850 cm1, 2930 cm1, and 2960 cm1. This region of
the spectrum is correlated with proteins and the carbonyl
chains of fatty acids (31). With increasing lengths of time
after TGFb1 stimulation, there was a gradual increase in
peak height across all peaks in this region (Fig. 3 B, bottom).
In contrast, coculture with MCF-7 cells yielded a fibroblast
response that was more defined, with a very rapid increase in
peak height at 2930 cm1 after just 6 h in comparison with
the control (Fig. 3 A, bottom). Although the immunofluores-
cence results show a-SMA expression in samples stimulated
with TGFb1 or cocultured with MCF-7 cells, the two sets of
samples show differences in absorption spectra, permitting
a more in-depth biochemical analysis of cellular activation.
The reasons for the difference in kinetics of activation likely
stem from the coculture providing a host of molecules in the
activation pathway via paracrine signaling. Although the
mechanisms of the two activations are likely different, this
would not be apparent from a single marker. It is also inter-
esting to contrast the ability of spectroscopy to measure
transient behavior, which is lacking in the expression of
a-SMA. Of course, vibrational spectroscopy does not pro-
vide specific protein expression levels in cells. As a general
strategy for comprehensive biomolecular analysis, the
spectroscopic data can be used to inform the search for
appropriate molecular markers by providing the temporal
evolution profiles. Further, cellular and subcellular spectral
heterogeneity across the sample may occur upon stimula-
tion. These issues have been examined elsewhere (36).
In contrast to the 2D Transwell coculture, culturing cells
in a 3D geometry provides an environment that is closer to
cellular chemistries in vivo. Cells are known to express
surface receptors more faithfully in 3D culture, and are
also more likely to differentiate in response to external
stimuli (37–39). In the 3D coculture system described
here, we used a single cell type and collagen scaffold to
fabricate a cylindrical-shaped layer (Fig. 1 B). Layers con-
taining different cell types were prepared separately and
subsequently stacked on top of each other. This technique
allowed for cells to be cocultured by simple stacking.
Because the layers are only weakly adherent, they could
subsequently be mechanically reseparated for analysis. As
described above for the 2D cell culture, we used immunoflu-
orescence staining for a-SMA to probe for the presence of
myofibroblasts in 3D by confocal microscopy (Fig. 2 C).
The immunofluorescence results remained consistent with
the Transwell coculture results, i.e., exposure to MCF-7
cells activated fibroblasts along the same time course as
TGFb1 exposure. Another advantage of the 3D cell culturein this setup is that the collagen peaks (1283 cm1,
1236 cm1, and 1204 cm1) can be used for IR spectral
analysis, either as a control or to examine microenviron-
mental changes associated with a growing tumor. These
collagen peaks are diagnostically useful for examinations
of whole tissue sections (15), and there is evidence that
changes in collagen spectra can be detected within a certain
distance from a tumor (30,40), which is clinically relevant
for cancer pathology. Therefore, we examined the same
peaks in the 3D coculture model (Fig. 4 A).
The major observation in the three-dimensional coculture
model was an overall increase in the absorption of the
collagen peaks after coculture with MCF-7 cells over time.
This could be a result of fibroblasts locally depositing
collagen upon exposure to MCF-7 stimuli. Myofibroblasts
play an important role in tissue maintenance, providing
a wound-healing-type response by depositing more collagen
in the surrounding extracellular matrix (41). TGFb1 also
stimulates fibroblasts to deposit collagen via the Smad
pathway, which aids in transcription of the a2(I) procollagen
gene, COL1A2 (42). It has been suggested that the fibroblasts
present in collagen-dense keloid scars aremore susceptible to
TGFb1 (43). Further, the extracellular matrix can act as a
controlmechanism for the involvement of TGFb1 in collagenBiophysical Journal 101(6) 1513–1521
FIGURE 5 Glandular and stromal regions observed in cancerous breast
tissue biopsies enable examination of a-SMA expression proximal to
cancerous epithelium. (A) The morphological features are distinguished
by H&E staining. (B) Fibroblasts are discerned by IHC staining for vimen-
tin. (C) IHC staining for a-SMA is positive for activated fibroblasts (myo-
fibroblasts), myoepithelium (found lining the gland), and smooth muscle
(found around blood vessels). a-SMA-positive fibroblasts are located adja-
cent to the cancerous epithelium, but distal fibroblasts are negative for this
protein. Each tissue core (part of a TMA) is 0.5 mm in diameter.
1518 Holton et al.biosynthesis (44). The other possibility is that upon fibroblast
activation, the stiffening of the cells themselves results in
contraction of the surrounding gel, making local regions
appear more collagen-dense in the absorption spectra.
However, no detectable gel contraction was observed upon
visual inspection during the time course of this experiment,
likely due to the low cell density of fibroblasts embedded
within the collagen matrix. For these reasons, we believe
that the spectral changes seen in this model are indicative
of collagen remodeling by cancer-activated fibroblasts.
Consistent with the 2D culture results, changes were seen
in the 1080 cm1 peak in the 3D culture model. There was
an increase in this peak initially; however, after 24 h this
peak had diminished. The ebb and flow of this nucleic
acid signature, even in the environment of persistent epithe-
lial cues, suggests that fibroblasts’ molecular expressions
settle into a new equilibrium upon an initial exposure to
transforming stimuli. This observation is also consistent
with changes seen in the Transwell coculture (Fig. 3,
bottom). There is no change in RNA levels (1224 cm1)
seen in this model compared with the Transwell-culture
model. This could be a result of diminished cytoplasmic
material from which to record data, because cells appear
smaller in the 3D matrix, and thus the cytoplasm is much
smaller compared with the nucleus of the cells. Peaks in
the C-H stretch region, as with other cultures, may correlate
with changes in the phospholipid membrane or protein
synthesis after fibroblast activation. Either explanation is
plausible considering the physiologic changes that occur
during the fibroblast-to-myofibroblast phenotypic change.
However, in the 12- and 24-h time points, there is a signifi-
cant decrease in absorption in this region compared with
the control. In general, absorbance in this area was low
compared with samples cultured in monolayers, because
cells in the 3D cultures were sparsely populated and thinner
than those in the 2D cultures. Thus, it is much more chal-
lenging to accurately monitor 3D cultures than 2D mono-
layers. In the C-H stretching region, biochemical changes
were dominated by events occurring in the cytoplasm of
cells (36), as were the changes at 1224 cm1. In the 3D
culture, as with tissues, it is productive to examine changes
due to cellular secretion of growth factors in the surrounding
extracellular matrix. However, an examination of changes
within the cells themselves requires a subcellular localiza-
tion of signals, which was not achieved here.
To translate the findings from these studies, we examined
clinical breast tissue samples by IR imaging and immuno-
histochemical staining, including for vimentin and a-SMA.
Vimentin (Fig. 5 B) will stain for fibroblasts and other
mesoderm-derived tissues. In contrast, a-SMA (Fig. 5 C)
is a protein that is found in myofibroblasts, myoepithelium
that lines each gland, and smooth muscle cells that surround
blood vessels. Hence, we were able to differentiate between
normal and activated fibroblasts by comparing the localiza-
tion of these two markers in adjacent sections of tissue. InBiophysical Journal 101(6) 1513–1521the clinical breast tissue samples, vimentin (in brown) is
primarily seen in the stroma between glands (Fig. 5 B).
However, only fibroblasts nearest the cancerous epithelium
express a-SMA (Fig. 5 C). This is a cancer-associated signa-
ture and is diagnostically relevant. To provide a critical
comparator with the work performed in our monolayer
and 3D coculture models, we examined spectral differences
between activated and resting-state fibroblasts in these clin-
ical samples. IR spectroscopic imaging was performed on
an entire TMA. Based on the staining of adjacent sections,
pixels were manually marked and classified as fibroblast
or myofibroblast. The pixels for each class were averaged
and these average spectra across the TMA were examined,
as shown in Fig. 6. Spectra were compared with the 3D
results, because this model should be biologically closest
to clinical samples. However, upon examination, the results
between the two models are inconsistent. Although the
collagen peaks (1300–1050 cm1) and C-H stretching
region (3000–2800 cm1) are consistent in shape between
the 3D culture model and the tissue sample, myofibroblasts
from the clinical samples show lower absorbance in the
biomolecular fingerprint region (Fig. 6 A). Spectra from
FIGURE 6 Pixels on a TMA were classified as fibroblasts or myofibro-
blasts based on their average spectra, as shown here. (A) Overall normalized
absorption was higher for the fibroblast class compared with myofibro-
blasts. (B) However, in the C-H stretching region, myofibroblasts show
stronger absorption compared with fibroblasts in the three peaks noted.
Label-Free Imaging of Fibroblasts 1519the 3D cultures were pure, i.e., they consisted of only
normal or activated fibroblasts and type I collagen. The
use of clinical samples is invaluable but leads to more
variables that become increasingly difficult to control.
For example, there is a large degree of variance between
patients, even for the noncancerous biopsies (M. J. Walsh,
unpublished data). Another interesting issue is whether
immunohistochemical stains, used here as the gold standard
for comparison, are truly as reliable in clinical samples as in
cell culture studies.
Across the three systems described here, activated
fibroblasts display spectral changes in the mid-IR regions
associated with nucleic acids (1080 cm1, 1224 cm1)
and C-H stretching modes (2850 cm1, 2930 cm1, and
2960 cm1). Although the 2D and 3D coculture models
were mostly consistent, we found some discrepancies
between the in vitro and clinical specimens. By studying
this transition with FTIR spectroscopy under controlled
cell culture conditions, we were able to obtain important
information about the potential kinetics of paracrine
signaling between epithelial cells and fibroblasts. An
investigation of the C-H stretching region of fibroblasts
showed an overall increased absorbance at all three peaks
across all scenarios, including human breast tissue biopsies(Fig. 6 B). The nature of fibroblast activation involves a
cellular phenotypic change whereby cytoplasmic proteins
are produced and the shape of the cell undergoes a transfor-
mation. These biological phenomena can be correlated
with the increased absorbance in peaks associated with
C-H stretching as a marker for a cancer-activated stromal
profile. Because FTIR spectroscopic imaging can be used
to study the distribution of chemical changes across the
area of a sample, this approach can also be applied to detect
early stromal activation in noncancerous areas of a biopsy
or tissue resection independently of the expression of a
biomarker. This same technique could be expanded to
different biological problems, such as testing the effects of
drug delivery on distal tissues. By correlating the biological
phenomena observed in cell cultures with chemical signa-
tures, we can achieve label-free imaging in complex human
tissues.
FTIR spectroscopy and imaging have been employed to
measure a wide variety of biomolecular species, including
nucleic acids, collagen, glycogen, proteins, and fatty acids.
The complex mixtures of these molecules present in cells
and tissues implies that IR spectroscopy is useful for deter-
mining global biochemical changes in classes of these
materials, and is sensitive to the metabolic (45) and local
physiologic state of the tissue. In this study, we demonstrate
that the method extracts more detailed changes compared
with conventional immunofluorescence. The correlations
of these changes with mechanistic molecular transitions in
the cell can now be established. This next step will link
many events in the transformation to a simple, label-free
measurement. Because IR imaging data are a convolution
of the underlying spectral and structural properties of the
tissue (46), the imaging setup (47–49), and optical proper-
ties (50–52), it is very challenging to measure specific
molecular alterations. Nevertheless, we have shown that
some changes in the fibroblast-to-myofibroblast transforma-
tion are conserved across monolayer and 3D cultures and
human tissues. In summary, IR absorption imaging provides
a label-free approach for integrated, first-pass approaches
that can yield information about changes in a sample.
Such information can provide a basis for studies by itself
or an early indication of which biological assays to perform
next, and is especially critical for heterogeneous samples in
which we need to determine where to perform further
molecular analysis.CONCLUSIONS
In this work, we examined adult NHDFs in monolayer and
3D cell cultures, as well as in formalin-fixed and paraffin-
embedded human tissues, to correlate the expression of
a-SMA (as observed by immunofluorescence techniques)
with chemical changes (as observed by FTIR spectroscopic
imaging). Spectral changes were observed predominantly in
the C-H stretching region (3290 cm1) and phosphate bondsBiophysical Journal 101(6) 1513–1521
1520 Holton et al.associated with nucleic acids (1224 cm1 and 1080 cm1).
In 3D cocultures and human tissue biopsies, we assessed
microenvironmental changes by examining vibrational
modes commonly associated with collagen (1283 cm1,
1236 cm1, and 1204 cm1). Fibroblasts activated in vitro
via TGFb1 stimulation or coculture with breast cancer epi-
thelial cells expressed a-SMA and were spectrally distinct
from resting-state fibroblast controls. This was also true
in the tissue biopsies. However, the spectra from cellular
cultures were not entirely consistent with those obtained
from tissue, particularly in the phosphate peaks. Although
the overall spectral characteristics were conserved between
the 3D culture and biopsies, specific absorbance values were
inconsistent. Furthermore, there was a spatial dependence
of this expression based on the distance of the fibroblasts
from the tumor source, as determined by analysis of the
collagen peaks and expression of a-SMA in tissue. By
directly extracting the spectral signatures of fibroblast
activation, the analysis presented here can potentially
provide new information, be conducted in a high-throughput
manner, and reduce variability, time, and costs. Finally, this
work represents a novel (to our knowledge) use of IR spec-
troscopic imaging to examine stromal changes associated
with tumor progression.SUPPORTING MATERIAL
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